KRYSTAL INTEGRATED SER L KRYSTAL NSEINFRA
Company Overview
Krystal Integrated Services Limited provides integrated and technical facility management, staffing, payroll and waste management, private security, manned guarding, and catering services in India. It operates through the Manpower and Related Service, Catering Service, and Information Technology Enabled Services segments. The company offers housekeeping, janitorial, disinfection and sanitation, and landscaping, industrial and commercial cleaning, pest control, and hygiene services; mechanical, electrical, and plumbing (MEP) maintenance services; solid, liquid and biomedical waste management, façade cleaning, HVAC upkeep, fire safety system inspections, and other engineering service; and warehouse and airport management services. It also offers workforce management services, such as recruitment, payroll processing, temporary staffing, and executive search; production support for manufacturing, logistics, and material handling; surveillance, access control, security audits, event security, and traffic control services; food preparation services; solid, liquid, and biomedical waste management solutions, including effluent treatment, CETP development, bio-mining of legacy waste, and Zero Liquid Discharge (ZLD) technologies; and HVAC and AHU maintenance services. Krystal Integrated Services Limited serves hospital, medical colleges, transit, healthcare, schools and colleges, education, hospitality, airport, railway, metro infrastructure, banking and financial services, entertainment, IT/ITES, manufacturing, industrial environments and hubs, transportation, and retail sectors, as well as state government entities, municipal bodies, and other government offices. The company was incorporated in 2000 and is based in Mumbai, India. Krystal Integrated Services Limited operates as a subsidiary of Krystal Family Holdings Private Limited.
Why Investors Should Care
Return on capital employed stands at 17.6%.
Net profit has compounded at 33.8% per year over the last five years.
Revenue has grown at a 21.8% CAGR over the past five years.
Trades at a P/E of 13.1, below the sector median of 29.6.
Carries low leverage with a debt-to-equity ratio of 0.24.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹1,277.28 Cr (+5.3% YoY); net profit ₹64.35 Cr.
- Trailing 12 Months Year-on-year growth — revenue +5.3%, earnings +2.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 21.8%, profit CAGR 33.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 21.76% |
| 1 Year: | 5.32% |
Compounded Profit Growth
| 5 Years: | 33.75% |
| 1 Year: | 2.94% |
Stock Price Performance
| 1 Year: | -10.06% |
| 6 Months: | +18.85% |
| 3 Months: | +9.96% |
| 1 Month: | +4.67% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)57.13 · Neutral
P/E of 13.10 is below the sector median of 29.60 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 21.8% over 5 years.
- Profit CAGR of 33.8% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYSTAL KRYSTAL INTEGRATED SER L NSEINFRA | 602.00 | 13.10 | ₹841.11 Cr | 0.25% | 17.63% | 12.89% | 21.76% | 33.75% |
| 2 | LT Larsen & Toubro Limited NIFTY50NSEAIINFRA | 3,849.40 | 32.93 | ₹5.30 L Cr | 0.96% | 14.55% | 14.72% | 16.09% | 15.38% |
| 3 | ADANIPORTS Adani Ports and Special Economic Zone Limited NIFTY50NSEINFRA | 1,834.20 | 31.50 | ₹4.23 L Cr | 0.42% | 10.97% | 13.32% | 22.93% | 34.11% |
| 4 | BEL Bharat Electronics Limited NIFTY50NSEAIDEFENCEINFRAPSU | 410.75 | 56.42 | ₹3.00 L Cr | 1.05% | 31.88% | 25.27% | 16.63% | 26.64% |
| 5 | HAL Hindustan Aeronautics Limited NSEAIDEFENCEINFRAPSU | 4,463.30 | 32.75 | ₹2.98 L Cr | 0.44% | 13.80% | 22.21% | 7.87% | 16.08% |
| 6 | INDIGO InterGlobe Aviation Limited NSEINFRA | 5,202.50 | -84.07 | ₹2.01 L Cr | 0.24% | 4.02% | -34.31% | 16.59% | -227.40% |
| 7 | CUMMINSIND Cummins India Limited NSEINFRA | 5,535.50 | 64.97 | ₹1.53 L Cr | 1.17% | 34.95% | 27.87% | 16.07% | 24.35% |
| 8 | ABB ABB India Limited NSEAIINFRA | 6,951.50 | 88.30 | ₹1.47 L Cr | 0.58% | 28.45% | 21.29% | 15.41% | 17.97% |
| 9 | POWERINDIA Hitachi Energy India Limited NIFTY_MIDNSEINFRA | 33,005.00 | 148.92 | ₹1.47 L Cr | 0.02% | 24.92% | 19.09% | 22.24% | 119.12% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 192.00 Cr | 217.00 Cr | 235.00 Cr | 283.00 Cr | 292.00 Cr | 257.00 Cr | - | - | 413.10 Cr | 323.08 Cr | 283.40 Cr | 305.86 Cr | 364.94 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 361.24 Cr | 286.68 Cr | 253.21 Cr | 274.44 Cr | 328.79 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 51.86 Cr | 36.40 Cr | 30.20 Cr | 31.42 Cr | 36.15 Cr |
| Operating Expenses | 183.00 Cr | 203.00 Cr | 218.00 Cr | 264.00 Cr | 273.00 Cr | 241.00 Cr | - | - | 27.56 Cr | 17.89 Cr | 15.40 Cr | 13.94 Cr | 15.23 Cr |
| Operating Income | 8.00 Cr | 12.00 Cr | 15.00 Cr | 17.00 Cr | 17.00 Cr | 14.00 Cr | - | - | 24.30 Cr | 18.51 Cr | 14.80 Cr | 17.48 Cr | 20.91 Cr |
| EBITDA | 10.00 Cr | 14.00 Cr | 17.00 Cr | 19.00 Cr | 19.00 Cr | 16.00 Cr | - | - | 30.90 Cr | 25.38 Cr | 22.41 Cr | 25.16 Cr | 29.84 Cr |
| Interest Expense | 3.00 Cr | 3.00 Cr | 3.00 Cr | 3.00 Cr | 3.00 Cr | 3.00 Cr | - | - | 2.78 Cr | 3.36 Cr | 3.50 Cr | 3.93 Cr | 5.25 Cr |
| Pretax Income | 7.00 Cr | 11.00 Cr | 15.00 Cr | 16.00 Cr | 16.00 Cr | 16.00 Cr | - | - | 25.67 Cr | 19.18 Cr | 15.80 Cr | 18.22 Cr | 21.73 Cr |
| Tax Provision | -1.75 Cr | 2.20 Cr | 2.85 Cr | 3.04 Cr | 64.00 L | 1.28 Cr | - | - | 8.76 Cr | 2.85 Cr | 2.62 Cr | 2.35 Cr | 2.92 Cr |
| Net Income | 9.00 Cr | 9.00 Cr | 12.00 Cr | 13.00 Cr | 16.00 Cr | 15.00 Cr | - | - | 16.93 Cr | 11.50 Cr | 9.21 Cr | 15.90 Cr | 18.85 Cr |
| Diluted EPS | 11.23 | 15.12 | 7.21 | 7.78 | 7.84 | 7.66 | - | - | 12.12 | 11.76 | 6.59 | 11.38 | 13.49 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 468.00 Cr | - | 707.64 Cr | 1,026.85 Cr | 1,212.78 Cr | 1,277.28 Cr |
| Cost of Revenue | - | - | 624.64 Cr | 930.60 Cr | 1,087.03 Cr | 1,143.12 Cr |
| Gross Profit | - | - | 83.00 Cr | 96.25 Cr | 125.75 Cr | 134.16 Cr |
| Operating Expenses | 447.00 Cr | - | 28.39 Cr | 33.28 Cr | 56.68 Cr | 62.45 Cr |
| Operating Income | 16.00 Cr | - | 54.61 Cr | 62.97 Cr | 69.08 Cr | 71.71 Cr |
| EBITDA | 21.00 Cr | - | 59.86 Cr | 75.24 Cr | 94.20 Cr | 102.80 Cr |
| Interest Expense | 10.00 Cr | - | 16.19 Cr | 10.54 Cr | 10.04 Cr | 16.05 Cr |
| Pretax Income | 16.00 Cr | - | 39.02 Cr | 57.55 Cr | 75.53 Cr | 74.93 Cr |
| Tax Provision | -32.00 L | - | 5.25 Cr | 8.53 Cr | 13.20 Cr | 10.73 Cr |
| Net Income | 17.00 Cr | - | 26.89 Cr | 34.33 Cr | 62.52 Cr | 64.35 Cr |
| Diluted EPS | 29.19 | - | 33.32 | 29.61 | 44.61 | 45.94 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Total Assets | 338.00 Cr | - | 343.47 Cr | 647.01 Cr | 760.67 Cr | 841.64 Cr |
| Current Assets | - | - | 205.53 Cr | 497.30 Cr | 583.94 Cr | 655.42 Cr |
| Cash & Equivalents | - | - | 9.37 Cr | 88.52 Cr | 18.39 Cr | 33.65 Cr |
| Inventory | - | - | 61.10 L | 63.50 L | 1.07 Cr | 1.97 Cr |
| Receivables | - | - | 149.61 Cr | 232.36 Cr | 363.36 Cr | 412.38 Cr |
| Total Liabilities | - | - | 180.06 Cr | 270.79 Cr | 323.46 Cr | 342.48 Cr |
| Current Liabilities | - | - | 158.39 Cr | 260.26 Cr | 313.19 Cr | 325.51 Cr |
| Long Term Debt | - | - | 19.75 Cr | 6.82 Cr | 4.41 Cr | 3.77 Cr |
| Total Debt | 68.00 Cr | - | 50.54 Cr | 87.69 Cr | 91.04 Cr | 119.74 Cr |
| Total Equity | 136.00 Cr | - | 163.41 Cr | 376.22 Cr | 437.21 Cr | 499.15 Cr |
| Shares Outstanding | - | - | 1.40 Cr | 1.40 Cr | 1.40 Cr | 1.40 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.00 Cr | - | 71.78 Cr | 2.27 Cr | -32.45 Cr | 26.46 Cr |
| Investing Cash Flow | 18.00 Cr | - | -32.01 Cr | -114.65 Cr | -33.98 Cr | -21.75 Cr |
| Financing Cash Flow | -27.00 Cr | - | -30.89 Cr | 191.53 Cr | -3.71 Cr | 10.55 Cr |
| Capital Expenditure | 4.00 Cr | - | -3.63 Cr | -12.31 Cr | -31.50 Cr | -15.79 Cr |
| Free Cash Flow | 12.00 Cr | - | 68.15 Cr | -10.04 Cr | -63.95 Cr | 10.67 Cr |
| Net Change in Cash | -1.00 Cr | - | 8.88 Cr | 79.15 Cr | -70.13 Cr | 15.26 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | 11.7% | 9.4% | 10.4% | 10.5% |
| Operating Margin % | 3.4% | - | 7.7% | 6.1% | 5.7% | 5.6% |
| Net Margin % | 3.6% | - | 3.8% | 3.3% | 5.2% | 5.0% |
| ROE % | 12.5% | - | 16.5% | 9.1% | 14.3% | 12.9% |
| ROCE % | - | - | 29.5% | 16.3% | 15.4% | 13.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for KRYSTAL
Is Krystal Biotech (KRYS) Too Expensive After A 440% Return? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxOeG1JZlk1bEItOC0tbHdfVGpyOWhLakV1anA4RVR5NUdTdEVwVTdFVlJWbC0zQ1IwdmhNU3hfTXN5MzJJU29fS3dzN09JY1g5cjBLMVAtbGRrVW41VFA3aVV1RG8zdUZuMThhUGJEcUFLUmdQVW50czc0Yzh4R1hYenBuT19vWDcyeDdyNH…
BofA raises Krystal Biotech stock price target on Vyjuvek growth - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPczFZVHd6SVN2YjhucGpSYlkyU3ZYNzZDRTJjWFFhMGp2QURJQUhLanJBdXQ4ODNjLWRXQ2tIaTllZDZkWThxUXJWblVKWTI2NV9vaUFfUkkzdUxoMVkzRTRzRG9aNkZDOVZENlozOW12eDNUZHpuOEVJQzFxZWNEampFVU5FdHdKSHpRU0…
Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $369.44, Implies 1% Upside - TradingView
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxNSXVVOUVXMzEzNmtxdlZvRGt1dUpTU2xWQVVwM24xb2szWGgtcS1GbG1wbVZ0QlNvdWo1eEUxVmQxWjZnMUc4bjJ4MEZFYnRNb3F5NE9DbWVNYzJEZE1VamhTWlBFVG5xVFAxSEhYV0RNS1pSY1k5QnJCWnVEbFlEZnlneXhWeDZFYk4xYl…
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPZ0NrR1ZIM1I5Uml4MWR0OFZ0b2JtSi1tRUZnY3hMcDRHaU5Ed1hGelZSQ0Jzci1QcF9mNjVoVEE0dDZ5aERkSC1IdW5rVjktbmJBZXFpLUVwM3Y4Y0RLejhMQVpVUUwxSFRRc2ZCT0p4SmE2Qy1IM2pJSW1YTWdWZzZrS2tQbVozNDV1UU…
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNV2t2QmRNaEktbWdTYTRseFZqRHE3NFV5Y1JHSGtaVFJIYi1Qd3hERUpzLU9hSzVISjVYdjE5NGlKN2VqZTRxWGFWSzZOclR3ek1iWkpTYURvdHpERWFXZDVOMnFpVy1jVlZQam1IVVJ5SGx4NHZ5NkJoMEt4RXdaMGJCdHhVaGVra0MwTX…
This Profitable Biotech Stealthily Climbs Into A Buy Zone - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPaVNHXzhzdXM1SldlUmxOWmtEc1BUOXc3YU5lLWQ0LUpwbENEdnhSNDMtRTZsQ0l3d2VkVi02OGN6R2RrVXY4dDVnZW5oTkN1MWpZZ2ZxNkxZNmR3VUYyM1FDUVJ4dGZINmJpbFB3Q0g0SG50WVFwWWRJODlEMldSZVJPbGJxMVNxT3J4Ul…
KRYSTAL — Frequently Asked Questions
What is the current share price of KRYSTAL INTEGRATED SER L (KRYSTAL)?
As of 2026-07-15 09:52 IST, KRYSTAL INTEGRATED SER L (KRYSTAL) trades at ₹602.00 on NSE. Its 52-week range is ₹505.10 to ₹697.15.
What is the market capitalisation of KRYSTAL?
KRYSTAL INTEGRATED SER L (KRYSTAL) has a market capitalisation of ₹841.11 Cr on NSE.
What is the P/E ratio of KRYSTAL?
KRYSTAL trades at a trailing price-to-earnings (P/E) ratio of 13.10. The industry average P/E is 29.60. Its price-to-book (P/B) ratio is 1.68.
Does KRYSTAL pay a dividend?
KRYSTAL INTEGRATED SER L (KRYSTAL) currently offers a dividend yield of 0.25%.
What is the return on equity (ROE) of KRYSTAL?
KRYSTAL has a return on equity (ROE) of 12.89%. Its return on capital employed (ROCE) is 17.63%.
Is KRYSTAL a good stock to buy?
This page provides a data-driven analysis of KRYSTAL INTEGRATED SER L (KRYSTAL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.